(Q37594158)

English

Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus

scientific article published on 25 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus (English)

1 reference

Europe PubMed Central

21 August 2017

chemoradiotherapy

0 references

squamous cell carcinoma

1 reference

based on heuristic

inferred from title

Yoshihiko Maehara

10

object named as

Yoshihiko Maehara

1 reference

Europe PubMed Central

21 August 2017

author name string

Tomonori Nakanoko

1

1 reference

Europe PubMed Central

21 August 2017

Hiroshi Saeki

2

1 reference

Europe PubMed Central

21 August 2017

Masaru Morita

3

1 reference

Europe PubMed Central

21 August 2017

Yuichiro Nakashima

4

1 reference

Europe PubMed Central

21 August 2017

Koji Ando

5

1 reference

Europe PubMed Central

21 August 2017

Eiji Oki

6

1 reference

Europe PubMed Central

21 August 2017

Takefumi Ohga

7

1 reference

Europe PubMed Central

21 August 2017

Yoshihiro Kakeji

8

1 reference

Europe PubMed Central

21 August 2017

Yasushi Toh

9

1 reference

Europe PubMed Central

21 August 2017

publication date

25 September 2013

1 reference

Europe PubMed Central

21 August 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

21 August 2017

21

1 reference

Europe PubMed Central

21 August 2017

2

1 reference

Europe PubMed Central

21 August 2017

597-604

1 reference

Europe PubMed Central

21 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

25 September 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1245/s10434-013-3220-2

0 references

Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

The effect of a DNA repair gene on cellular invasiveness: XRCC3 over-expression in breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Overexpression of RAD51 occurs in aggressive prostatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Randomized clinical trials in esophageal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Clinical relevance of the homologous recombination machinery in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Pulmonary complications after esophagectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

23 August 2017

Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

6 September 2017

Down-regulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small-cell lung cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

14 September 2017

Targeting DNA double-strand break repair: is it the right way for sensitizing cells to 5-fluorouracil?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

14 September 2017

Elevated levels of Rad51 recombination protein in tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

28 September 2017

BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

28 September 2017

BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

28 September 2017

Role of the human RAD51 protein in homologous recombination and double-stranded-break repair

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

25 June 2018

Effect of DNA-damaging agents on DNA replication and cell-cycle progression of cultured mouse mammary carcinoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

25 June 2018

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

1 September 2018

Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

1 September 2018

Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

1 September 2018

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

1 September 2018

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

1 September 2018

Proliferative activity of cancer cells in front and center areas of carcinoma in situ and invasive sites of esophageal squamous-cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

1 September 2018

Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3929771

5 November 2018

Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemoradiotherapy for clinical stage II-III esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple pathways of recombination define cellular responses to cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of sulphur mustard or cisplatin-induced toxicity by caffeine in Chinese hamster cells correlates with formation of DNA double-strand breaks during replication on a damaged template

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged chemotherapy for localised squamous carcinoma of the oesophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of p53 and p21 and the clinical response for hyperthermochemoradiotherapy in patients with squamous cell carcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065387

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1245/S10434-013-3220-2

1 reference

Europe PubMed Central

21 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37594158&oldid=1863931566"